{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:51:07Z","timestamp":1790351467427,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI20C1586"],"award-info":[{"award-number":["HI20C1586"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI20C1586"],"award-info":[{"award-number":["HI20C1586"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.bloodresearch.or.kr"],"crossmark-restriction":true},"short-container-title":["Blood Res"],"published-print":{"date-parts":[[2023,4,30]]},"DOI":"10.5045\/br.2023.2023017","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T02:07:56Z","timestamp":1678327676000},"page":"S29-S36","update-policy":"https:\/\/doi.org\/10.5045\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Asciminib: the first-in-class allosteric inhibitor of BCR::ABL1 kinase"],"prefix":"10.1007","volume":"58","author":[{"given":"Eun-Ji","family":"Choi","sequence":"first","affiliation":[{"name":"Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.66.2866"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.253"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902328"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009984"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.6565"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.85"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.8899"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-510396"},{"key":"ref9","unstructured":"National Comprehensive Cancer Network. Chronic myeloid leukemia. Version 1.2023. Plymouth Meeting, PA: NCCN, 2022 (Accessed January 5, 2022, at https:\/\/nccn.org\/professionals\/physician_gls\/pdf\/cml.pdf)."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx219"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0776-2"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609324"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01111-2"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01589-y"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24423"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.181"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24536"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-739086"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0842-9"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2015.03.006"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051542"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5045\/br.2021.2020260"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01040"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1701"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106458"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/nature21702"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.08.004"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.264"},{"key":"ref30","unstructured":"Gleixner KV, Filik Y, Berger D, et al. Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1T315I-compound mutations. Am J Cancer Res 2021;11:4470-84."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000561812.22500.d8"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000561816.04574.8b"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-214221"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.21.8230"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-660977"}],"container-title":["Blood Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/BR\/2023\/058\/BR2058-S1-S29.pdf","content-type":"unspecified","content-version":"tdm","intended-application":"text-mining"},{"URL":"http:\/\/pdf.medrang.co.kr\/BR\/2023\/058\/BR2058-S1-S29.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T22:27:23Z","timestamp":1773354443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bloodresearch.or.kr\/journal\/view.html?doi=10.5045\/br.2023.2023017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":35,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2023,4,30]]}},"alternative-id":["10.5045\/br.2023.2023017"],"URL":"https:\/\/doi.org\/10.5045\/br.2023.2023017","relation":{},"ISSN":["2287-979X","2288-0011"],"issn-type":[{"value":"2287-979X","type":"print"},{"value":"2288-0011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,9]]},"assertion":[{"value":"https:\/\/www.bloodresearch.or.kr\/journal\/view.html?doi=10.5045\/br.2023.2023017","URL":"https:\/\/www.bloodresearch.or.kr\/journal\/view.html?doi=10.5045\/br.2023.2023017","name":"the_journal","label":"Blood Res","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"2023-01-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-09","order":3,"name":"published","label":"Online First","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-30","order":4,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2023 The Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:\/\/creativecommons.org\/licenses\/by-nc\/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}